Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Teladoc Health, Inc. (TDOC)
|
Add to portfolio |
|
|
|
| Price: |
$95.08
| | Metrics |
| OS: |
165.0
|
M
| |
|
|
| Market cap: |
$15.7
|
B
| |
|
|
|
Net debt:
|
$578
|
M
| |
|
|
|
EV:
|
$16.3
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Jun-30-16 |
| Revenues | 2,406.8 | 2,032.7 | 1,094.0 | 553.3 | 417.9 | 233.3 | 123.2 | 53.4 |
| Revenue growth | 18.4% | 85.8% | 97.7% | 32.4% | 79.1% | 89.4% | 59.2% | 53.5% |
| Cost of goods sold | 744.0 | 650.3 | 390.8 | 184.5 | 128.7 | 61.6 | 32.0 | 14.8 |
| Gross profit | 1,662.9 | 1,382.4 | 703.1 | 368.8 | 289.2 | 171.7 | 91.2 | 38.5 |
| Gross margin | 69.1% | 68.0% | 64.3% | 66.7% | 69.2% | 73.6% | 74.0% | 72.2% |
| Selling, general and administrative | | | | 449.3 | | | | |
| Sales and marketing | 850.7 | 667.3 | 380.2 | | 144.3 | 95.6 | 61.0 | 27.0 |
| Research and development | 333.6 | 311.9 | 164.9 | | 54.4 | 34.5 | 21.8 | 10.1 |
| General and administrative | 449.9 | 438.0 | 506.7 | | 116.9 | 79.8 | 48.6 | 23.2 |
| EBITA | 9.8 | -43.7 | -353.5 | -44.8 | -39.4 | -60.1 | -45.5 | -29.2 |
| EBITA margin | 0.4% | -2.1% | -32.3% | -8.1% | -9.4% | -25.8% | -36.9% | -54.7% |
| Amortization of intangibles | 244.6 | 195.3 | 64.7 | 35.6 | 31.5 | 15.3 | 6.1 | |
| EBIT | -234.8 | -239.0 | -418.2 | -80.4 | -70.9 | -75.4 | -51.6 | -29.2 |
| EBIT margin | -9.8% | -11.8% | -38.2% | -14.5% | -17.0% | -32.3% | -41.9% | -54.7% |
| Pre-tax income | -13,663.3 | -384.7 | -576.0 | -109.5 | -97.0 | -107.0 | -73.7 | -30.0 |
| Income taxes | -3.8 | 44.1 | -90.9 | -10.6 | 0.1 | -0.2 | 0.5 | 0.2 |
| Tax rate | 0.0% | | 15.8% | 9.7% | | 0.2% | | |
| Net income | -13,659.5 | -428.8 | -485.1 | 0.0 | -97.1 | -106.8 | -74.2 | -30.2 |
| Net margin | -567.5% | -21.1% | -44.3% | 0.0% | -23.2% | -45.8% | -60.3% | -56.5% |
| |
| Diluted EPS | ($84.60) | ($2.73) | ($5.36) | $0.00 | ($1.47) | ($1.93) | ($1.75) | ($0.78) |
| Shares outstanding (diluted) | 161.5 | 156.9 | 90.5 | 71.8 | 65.8 | 55.4 | 42.3 | 38.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|